OI
PFE icon

Oakbrook Investments’s Pfizer PFE Stock Holding History

Oakbrook Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$702K Sell
22,661
-74,435
-77% -$2.54M 1.79% 18
2019
Q4 		$3.61M Buy
97,096
+36,625
+61% +$1.3M 0.73% 17
2019
Q3 		$2.06M Sell
60,471
-112,409
-65% -$4.09M 0.13% 109
2019
Q2 		$7.11M Sell
172,880
-33,069
-16% -$1.31M 0.43% 42
2019
Q1 		$8.3M Sell
205,949
-11,700
-5% -$469K 0.5% 39
2018
Q4 		$9.01M Sell
217,649
-3,415
-2% -$142K 0.61% 34
2018
Q3 		$9.24M Buy
221,064
+114,011
+106% +$4.39M 0.51% 41
2018
Q2 		$3.69M Sell
107,053
-1,828
-2% -$62.5K 0.23% 74
2018
Q1 		$3.67M Sell
108,881
-102,470
-48% -$3.52M 0.23% 72
2017
Q4 		$7.26M Sell
211,351
-87,219
-29% -$2.97M 0.46% 47
2017
Q3 		$10.1M Sell
298,570
-54,597
-15% -$1.75M 0.65% 36
2017
Q2 		$11.3M Sell
353,167
-35,994
-9% -$1.14M 0.75% 34
2017
Q1 		$12.6M Sell
389,161
-43,899
-10% -$1.38M 0.82% 35
2016
Q4 		$13.3M Sell
433,060
-128,430
-23% -$3.92M 0.87% 34
2016
Q3 		$18M Buy
561,490
+134,227
+31% +$4.49M 1.1% 27
2016
Q2 		$14.3M Buy
427,263
+267,505
+167% +$8.54M 0.79% 35
2016
Q1 		$4.49M Sell
159,758
-392,446
-71% -$11.2M 0.29% 73
2015
Q4 		$16.9M Sell
552,204
-12,144
-2% -$382K 1.08% 22
2015
Q3 		$16.8M Buy
564,348
+126,163
+29% +$4.05M 1.1% 20
2015
Q2 		$13.9M Buy
438,185
+195,061
+80% +$6.36M 0.85% 32
2015
Q1 		$8.03M Sell
243,124
-442,891
-65% -$14.1M 0.43% 55
2014
Q4 		$20.3M Sell
686,015
-98,187
-13% -$2.82M 1.09% 24
2014
Q3 		$22M Sell
784,202
-743,326
-49% -$20.9M 1.18% 18
2014
Q2 		$43M Buy
1,527,528
+53,821
+4% +$1.53M 1.3% 15
2014
Q1 		$44.9M Sell
1,473,707
-386,506
-21% -$11.5M 1.42% 11
2013
Q4 		$54.1M Sell
1,860,213
-7,022
-0.4% -$204K 1.5% 9
2013
Q3 		$50.9M Sell
1,867,235
-259,625
-12% -$7.06M 1.49% 7
2013
Q2 		$56.5M Buy
+2,126,860
New +$58.8M 1.64% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Oakbrook Investments's PFE Position: Q1 2020 in Review

Oakbrook Investments reduced its Pfizer (PFE) stake by 77% in Q1 2020, selling an estimated $2.54M and leaving 22,661 shares worth $702K. The position accounts for 1.79% of the portfolio, ranked #18.

Oakbrook Investments first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. The position peaked at $56.5M in Q2 2013. 2,436 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Oakbrook Investments held 22,661 shares of Pfizer worth $702K as of Q1 2020.
  • Oakbrook Investments sold 74,435 Pfizer shares in Q1 2020, an estimated $2.54M.
  • Pfizer made up 1.79% of Oakbrook Investments's portfolio in Q1 2020, its #18 holding.
  • Oakbrook Investments first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's Pfizer position peaked at $56.5M in Q2 2013.
  • 2,436 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.